Research output per year
Research output per year
Research activity per year
https://www.kuball-laboratories.com/jurgen-kuball
http://nl.linkedin.com/pub/jurgen-kuball/88/156/49b
Prof. Dr. Jürgen Kuball is Chair of the Department of Hematology, and Director of the Bone Marrow Transplantation Program at the UMC Utrecht Cancer Centre. His research activities focus on tumor immunology and the ATMP development of a next generation of engineered immune cells, with an emphasis on the therapeutic potential of individual receptors derived from γδT cells. His clinical activities focus around acute leukemia and allogeneic stem cell transplantation. He is an active member of European Society for Blood and Marrow Transplantation (EBMT), and has chaired the Legal Regulatory Affairs Committee of the EBMT since 2019.
Dr. Kuball received his medical degree in Hematology at the University of Mainz, Germany, and completed his post-doctoral fellowship at the Fred Hutchinson Cancer Center in Seattle, WA, USA. He joined the Department of Hematology at the UMC Utrecht in 2007 as a hematologist and immunologist. In 2010, he became a VIDI-laureate, and the chair of the Applied & Tumor-Immunology section within the Laboratory of Translation Immunology. He has chaired the Department of Hematology (adults) since 2013.
For more information on experimental and translational research please visit Kuball Laboratories
American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)
aandeelhouder - shareholder via Gadeta Founders - Century Therapeutics & Adeta
1 Jan 2024 → 31 Dec 3999
Chair - Chairing - Immunology Community Life Science
1 Jan 2023 → 31 Dec 3999
Secretary team member - bestuurslid - GoCART Coalition (EBMT/EHA)
1 Jan 2023 → 31 Dec 3999
Inkomsten licentie - Onderzoek - UMCU Holding
1 Jan 2022 → 31 Dec 3999
Commissie lid PPS commissie - grant indieningen voor KWF beoordelen - KWF
1 Jan 2022 → 31 Dec 3999
aandeelhouder - Receiving revenues from licensed patents via UMCU - UMC Holding
1 Jan 2021 → 31 Dec 3999
Chair legal and rgulatory affairs committee - Chair - EBMT
1 Jan 2019 → 31 Dec 3999
grant - grant ontvangen voor onderzoek - Novartis
1 Jan 2015 → 31 Dec 3999
Onderzoeker - grant ontvangen voor onderzoek - Miltenyi
1 Jan 2015 → 31 Dec 3999
bestuurslid - member general Board - HOVON
1 Jan 2014 → 31 Dec 3999
Patent holder multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs &Miltenyi - Patent houder - Various
1 Jan 2013 → 31 Dec 3999
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Letter › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Leusen, J. (Keynote/plenary speaker) & Kuball, J. (Invited speaker)
Activity: Participating in or organising an event › Participation in conference › Academic
Clevers, H. (Interviewee), Fuchs, S. A. (Interviewee), Kuball, J. (Interviewee) & Bredenoord, A. L. (Interviewee)
Activity: Other › Types of Public engagement and outreach - Media article or participation